These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 7925587

  • 1. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
    Marona-Lewicka D, Nichols DE.
    Eur J Pharmacol; 1994 Jun 02; 258(1-2):1-13. PubMed ID: 7925587
    [Abstract] [Full Text] [Related]

  • 2. Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
    Marona-Lewicka D, Nichols DE.
    Psychopharmacology (Berl); 1998 Jul 02; 138(1):67-75. PubMed ID: 9694528
    [Abstract] [Full Text] [Related]

  • 3. Psychostimulant-like effects of p-fluoroamphetamine in the rat.
    Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE.
    Eur J Pharmacol; 1995 Dec 12; 287(2):105-13. PubMed ID: 8749023
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R, Nichols DE.
    J Pharmacol Exp Ther; 1990 Dec 12; 255(3):1098-106. PubMed ID: 1979813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reinforcing effects of certain serotonin-releasing amphetamine derivatives.
    Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE.
    Pharmacol Biochem Behav; 1996 Jan 12; 53(1):99-105. PubMed ID: 8848466
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA).
    Johnson MP, Frescas SP, Oberlender R, Nichols DE.
    J Med Chem; 1991 May 12; 34(5):1662-8. PubMed ID: 1674539
    [Abstract] [Full Text] [Related]

  • 10. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
    Johnson MP, Conarty PF, Nichols DE.
    Eur J Pharmacol; 1991 Jul 23; 200(1):9-16. PubMed ID: 1685125
    [Abstract] [Full Text] [Related]

  • 11. Drug discrimination studies with MDMA and amphetamine.
    Oberlender R, Nichols DE.
    Psychopharmacology (Berl); 1988 Jul 23; 95(1):71-6. PubMed ID: 2898791
    [Abstract] [Full Text] [Related]

  • 12. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
    Baker LE, Taylor MM.
    Pharmacol Biochem Behav; 1997 Aug 23; 57(4):737-48. PubMed ID: 9259001
    [Abstract] [Full Text] [Related]

  • 13. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM, Appel JB.
    J Pharmacol Exp Ther; 1988 Sep 23; 246(3):866-70. PubMed ID: 2901488
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination.
    Goodwin AK, Pynnonen DM, Baker LE.
    Pharmacol Biochem Behav; 2003 Mar 23; 74(4):987-95. PubMed ID: 12667914
    [Abstract] [Full Text] [Related]

  • 17. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW, Wing LL, Geyer MA.
    J Pharmacol Exp Ther; 1990 Aug 23; 254(2):456-64. PubMed ID: 1974635
    [Abstract] [Full Text] [Related]

  • 18. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine.
    White FJ, Appel JB.
    Psychopharmacology (Berl); 1981 Aug 23; 73(2):110-5. PubMed ID: 6785800
    [Abstract] [Full Text] [Related]

  • 19. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL, Callaway CW, Geyer MA.
    Neuropsychopharmacology; 1993 May 23; 8(3):201-11. PubMed ID: 8099482
    [Abstract] [Full Text] [Related]

  • 20. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D, Thisted RA, Nichols DE.
    Psychopharmacology (Berl); 2005 Jul 23; 180(3):427-35. PubMed ID: 15723230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.